MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1878313
Sentiment: neutral
Topics: corporate-filing, sec-filing
TL;DR
MAIA Bio filed an 8-K on 3/19/25, standard corporate update.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on March 19, 2025, reporting other events and financial statements. The filing details the company's incorporation in Delaware, its principal executive offices in Chicago, IL, and its standard industrial classification in Pharmaceutical Preparations.
Why It Matters
This filing provides an official update on MAIA Biotechnology's corporate and financial reporting status with the SEC.
Risk Assessment
Risk Level: low — This is a routine corporate filing with no immediate financial or operational news.
Key Numbers
- 001-41455 — SEC File Number (Identifies the company's filing with the SEC.)
- 83-1495913 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- March 19, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Chicago, IL (location) — Address of principal executive offices
- 312-416-8592 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 19, 2025.
When was MAIA Biotechnology, Inc. incorporated?
MAIA Biotechnology, Inc. was incorporated in Delaware.
What is the company's principal executive office address?
The company's principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is MAIA Biotechnology's Standard Industrial Classification code?
MAIA Biotechnology's Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for MAIA Biotechnology?
The SEC file number for MAIA Biotechnology, Inc. is 001-41455.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding MAIA Biotechnology, Inc. (MAIA).